FDA Requires Boxed Warning for Promethazine Hydrochloride Injection

Links shared publicly online about this topic.

1,745
total visits

FDA Requires Boxed Warning for Promethazine Hydrochloride Injection

The U.S. Food and Drug Administration is telling manufacturers of the drug promethazine to include a boxed warning regarding the injectable form of the drug. The warning, under FDAâ€™s authority to require safety labeling changes, will highlight the risk of serious tissue injury when this drug is administered incorrectly. The agency is also alerting health care professionals to the new boxed warning for this product, which is used as a sedative and to treat nausea and vomiting.

View full resource at fda.gov

Tags: Nausea, Vomiting, Nausea and Vomiting Medication, Drug, Healthcare, FDA, Phenergan, Pentazine

Most Recently Shared on September 17, 2009 at 4:36 pm By:

Gannett Healthcare

FDA Requires Boxed Warning for Promethazine Hydrochloride Injection: http://bit.ly/Fwp4s

3 years ago...

Retweet

Favorite

Also Shared By:

eyeonfda

HemOnc Today

Physician Assistants

FDA Alert: Promethazine Hydrochloride Injection

drugs.com — “FDA Alert: Promethazine Hydrochloride Injection” View full resource at drugs.com

Most Recently Shared on September 16, 2009 at 10:59 pm By:

Drugs.com Health Site

FDA Alert - Boxed Warning for Promethazine Hydrochloride Injection - http://bit.ly/NZA6l

3 years ago...

Retweet

Favorite

Promethazine Hydrochloride Injection

fda.gov — “Boxed Warning added to labeling, describing risks of severe tissue injury, including gangrene, following intravenous administration of promethazine.” View full resource at fda.gov

Most Recently Shared on September 16, 2009 at 8:12 pm By:

Barbara Olson Nurse

Promethazine (Phenergan) gets FDA black box. #nurses #drugs #RT http://bit.ly/106CZB

3 years ago...

Retweet

Favorite

Promethazine injection gains boxed warning - MPR

empr.com — “The FDA has notified healthcare professionals that a Boxed Warning is being added to the prescribing information for promethazine hydrochloride products, describing the risks of severe tissue injury, including gangrene, requiring amputation following intravenous administration of promethazine.” View full resource at empr.com